@article{cdc751e5a7274e38b0635162073782f9,
title = "Value-added opportunistic CT: Insights into osteoporosis and sarcopenia",
abstract = "OBJECTIVE. The purpose of this article is to review the emerging field of opportunistic CT, which can be used to screen patients for osteoporosis and sarcopenia. CONCLUSION. Although body composition measurements are not routinely obtained using CT, quantitative assessment of bone and muscle biomarkers on CT can add value to patient care. Automated bone and muscle measurements promise to transform the everyday practice of radiology without resulting in additional cost or radiation exposure for patients.",
keywords = "CT, Muscle, Musculoskeletal, Osteoporosis, Sarcopenia",
author = "Boutin, {Robert D.} and Leon Lenchik",
note = "Funding Information: Supported by grant P30 AG021332 from the National Institutes of Health Pepper Center. Funding Information: Sarcopenia is broadly defined by the loss of muscle mass and muscle function. In clinical practice and clinical research, sarcopenia has been defined by expert consensus panels including the European Working Group on Sarcopenia in Older People, the Asian Working Group for Sarcopenia, the International Working Group on Sarcopenia, the Foundation for the National Institutes of Health Sar-copenia Project, and the Sarcopenia Definitions and Outcomes Consortium supported by the Foundation for the National Institutes of Health Sarcopenia Project. These definitions rely on measurements of physical function that include slow walking speed (e.g., ≤ 0.8 m/s) and low grip strength (e.g., < 27 kg for men and < 16 kg for woman) [82]. Among older adults, both slow gait and weak grip are established risk factors for disability and mortality.",
year = "2020",
month = sep,
doi = "10.2214/AJR.20.22874",
language = "English (US)",
volume = "215",
pages = "582--594",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",
}